Prevention of VTE in Nonsurgical Patients

Gould, 2012, Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, e227S, 10.1378/chest.11-2297

Lansberg, 2012, Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, e601S, 10.1378/chest.11-2302

Guyatt, 2012, Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, 53S, 10.1378/chest.11-2288

MacLean, 2012, Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, e1S, 10.1378/chest.11-2290

Cohen, 2005, Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients, Thromb Haemost, 94, 750

Spyropoulos, 2010, Risk assessment of venous thromboembolism in hospitalized medical patients, Curr Opin Pulm Med, 16, 419, 10.1097/MCP.0b013e32833b4669

Spyropoulos, 2011, Predictive and associative models to identify hospitalized medical patients at risk for venous thromboembolism, Chest, 140, 706, 10.1378/chest.10-1944

Kucher, 2005, Electronic alerts to prevent venous thromboembolism among hospitalized patients, N Engl J Med, 352, 969, 10.1056/NEJMoa041533

Barbar, 2010, A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score, J Thromb Haemost, 8, 2450, 10.1111/j.1538-7836.2010.04044.x

Decousus, 2011, Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators, Chest, 139, 69, 10.1378/chest.09-3081

Shorr, 2009, Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis, Thromb Haemost, 101, 139, 10.1160/TH08-07-0468

The PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group, 2011, Dalteparin versus unfractionated heparin in critically ill patients, N Engl J Med, 364, 1305, 10.1056/NEJMoa1014475

Cook, 2000, Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients, J Crit Care, 15, 127, 10.1053/jcrc.2000.19224

Lentine, 2005, Variability in the use of thromboprophylaxis and outcomes in critically ill medical patients, Am J Med, 118, 1373, 10.1016/j.amjmed.2004.12.025

Muscedere, 2007, Venous thromboembolism in critical illness in a community intensive care unit, J Crit Care, 22, 285, 10.1016/j.jcrc.2007.02.003

Heit, 2000, Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study, Arch Intern Med, 160, 809, 10.1001/archinte.160.6.809

Heit, 2002, Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study, Arch Intern Med, 162, 1245, 10.1001/archinte.162.11.1245

Spencer, 2007, Venous thromboembolism in the outpatient setting, Arch Intern Med, 167, 1471, 10.1001/archinte.167.14.1471

Goldhaber, 2000, New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment, Chest, 118, 1680, 10.1378/chest.118.6.1680

Alikhan, 2004, Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study, Arch Intern Med, 164, 963, 10.1001/archinte.164.9.963

Anderson, 2003, Risk factors for venous thromboembolism, Circulation, 107, I9

Lijfering, 2010, Risk factors for venous thrombosis - current understanding from an epidemiological point of view, Br J Haematol, 149, 824, 10.1111/j.1365-2141.2010.08206.x

Alikhan, 2009, Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction), Cochrane Database Syst Rev, CD003747

Dentali, 2007, Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients, Ann Intern Med, 146, 278, 10.7326/0003-4819-146-4-200702200-00007

Lloyd, 2008, Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis, J Thromb Haemost, 6, 405, 10.1111/j.1538-7836.2007.02847.x

Bergmann, 1996, A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness, Thromb Haemost, 76, 529, 10.1055/s-0038-1650617

Forette, 1995, Calcium nadroparin in the prevention of thromboembolic disease in elderly subjects. Study of tolerance [in French], Presse Med, 24, 567

Kleber, 2003, Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease, Am Heart J, 145, 614, 10.1067/mhj.2003.189

Lechler, 1996, The venous thrombotic risk in nonsurgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin), Haemostasis, 26, 49

Riess, 2010, A randomized, double-blind study of certoparin versus unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY study, J Thromb Haemost, 8, 1209, 10.1111/j.1538-7836.2010.03848.x

Tapson, 2007, Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism, Chest, 132, 936, 10.1378/chest.06-2993

Phung, 2011, Murad MH. Dosing frequency of unfractionated heparin thromboprophylaxis: A meta-analysis, Chest, 140, 374, 10.1378/chest.10-3084

Pechevis, 2000, Economic evaluation of enoxaparin vs. placebo for the prevention of venous thromboembolism in acutely ill medical patients, Value Health, 3, 389, 10.1046/j.1524-4733.2000.36008.x

Nuijten, 2003, Cost-effectiveness of enoxaparin as thromboprophylaxis in acutely ill medical patients in Spain, Value Health, 6, 126, 10.1046/j.1524-4733.2003.00210.x

Lamy, 2002, Economic evaluation of the MEDENOX trial: a Canadian perspective. Medical Patients with Enoxaparin, Can Respir J, 9, 169, 10.1155/2002/310841

Pineo, 2009, Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patients, Clin Appl Thromb Hemost, 15, 489, 10.1177/1076029609335910

Leykum, 2006, Cost utility of substituting enoxaparin for unfractionated heparin for prophylaxis of venous thrombosis in the hospitalized medical patient, J Hosp Med, 1, 168, 10.1002/jhm.97

Lloyd, 2001, Economic evaluation of the use of enoxaparin for thromboprophylaxis in acutely ill medical patients, J Med Econ, 4, 99, 10.3111/200104099113

McGarry, 2004, Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients, Am J Manag Care, 10, 632

Offord, 2004, Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients, Pharm World Sci, 26, 214, 10.1023/B:PHAR.0000035887.23072.e5

Shorr, 2007, Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis, Blood Coagul Fibrinolysis, 18, 309, 10.1097/MBC.0b013e328099af58

Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103

Morris, 2007, No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis, Chest, 132, 1131, 10.1378/chest.06-2518

Benkö, 2001, Graduated compression stockings: knee length or thigh length, Clin Orthop Relat Res, 383, 197, 10.1097/00003086-200102000-00022

Kierkegaard, 1993, Graduated compression stockings in the prevention of deep vein thrombosis in patients with acute myocardial infarction, Eur Heart J, 14, 1365, 10.1093/eurheartj/14.10.1365

Dennis, 2009, Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial, Lancet, 373, 1958, 10.1016/S0140-6736(09)60941-7

Muir, 2000, Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke, QJM, 93, 359, 10.1093/qjmed/93.6.359

CLOTS (Clots in Legs Or sTockings after Stroke) Trial Collaboration, 2010, Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial, Ann Intern Med, 153, 553, 10.7326/0003-4819-153-9-201011020-00280

Kearon, 2010, Should patients with stroke wear compression stockings to prevent venous thromboembolism?, Ann Intern Med, 153, 610, 10.7326/0003-4819-153-9-201011020-00285

Roderick, 2005, Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis, Health Technol Assess, 9, 1, 10.3310/hta9490

Eppsteiner, 2010, Mechanical compression versus subcutaneous heparin therapy in postoperative and posttrauma patients: a systematic review and meta-analysis, World J Surg, 34, 10, 10.1007/s00268-009-0284-z

Comerota, 1992, Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail?, Am J Surg, 164, 265, 10.1016/S0002-9610(05)81083-9

Cornwell, 2002, Compliance with sequential compression device prophylaxis in at-risk trauma patients: a prospective analysis, Am Surg, 68, 470, 10.1177/000313480206800515

Murakami, 2003, Deep venous thrombosis prophylaxis in trauma: improved compliance with a novel miniaturized pneumatic compression device, J Vasc Surg, 38, 923, 10.1016/S0741-5214(03)00792-4

Falck-Ytter, 2012, Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, e278S, 10.1378/chest.11-2404

Hull, 2010, Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial, Ann Intern Med, 153, 8, 10.7326/0003-4819-153-1-201007060-00004

Antiplatelet Trialists' Collaboration, 1994, Collaborative overview of randomised trials of antiplatelet therapy—III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration, BMJ, 308, 235, 10.1136/bmj.308.6923.235

Pulmonary Embolism Prevention (PEP) Trial Collaborative Group, 2000, Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial, Lancet, 355, 1295, 10.1016/S0140-6736(00)02110-3

Robinson, 1997, Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial, Ann Intern Med, 127, 439, 10.7326/0003-4819-127-6-199709150-00004

Furlan, 2007, Role of screening tests for deep venous thrombosis in asymptomatic adults with acute spinal cord injury: an evidence-based analysis, Spine (Phila Pa 1976), 32, 1908, 10.1097/BRS.0b013e31811ec26a

Cohen, 2008, Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study, Lancet, 371, 387, 10.1016/S0140-6736(08)60202-0

Geerts, 2008, Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 381S, 10.1378/chest.08-0656

Goldhaber, 2004, A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis, Am J Cardiol, 93, 259, 10.1016/j.amjcard.2003.09.057

Tooher, 2005, A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals, Ann Surg, 241, 397, 10.1097/01.sla.0000154120.96169.99

Piazza, 2009, Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients, Circulation, 119, 2196, 10.1161/CIRCULATIONAHA.108.841197

Schünemann, 2004, Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 688S, 10.1378/chest.126.3_suppl.688S

Cook, 2005, Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors, Crit Care Med, 33, 1565, 10.1097/01.CCM.0000171207.95319.B2

Arnold, 2007, Bleeding during critical illness: a prospective cohort study using a new measurement tool, Clin Invest Med, 30, E93, 10.25011/cim.v30i2.985

Fraisse, 2000, Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD, Am J Respir Crit Care Med, 161, 1109, 10.1164/ajrccm.161.4.9807025

Cook, 2008, Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors, Crit Care, 12, R32, 10.1186/cc6810

Cade, 1982, High risk of the critically ill for venous thromboembolism, Crit Care Med, 10, 448, 10.1097/00003246-198207000-00006

De, 2010, Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery, Blood Coagul Fibrinolysis, 21, 57, 10.1097/MBC.0b013e3283333505

Kakkos, 2008, Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients, Cochrane Database Syst Rev, CD005258

Blom, 2005, Rosendaal FR Malignancies, prothrombotic mutations, and the risk of venous thrombosis, JAMA, 293, 715, 10.1001/jama.293.6.715

Alcalay, 2006, Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival, J Clin Oncol, 24, 1112, 10.1200/JCO.2005.04.2150

Chew, 2006, Incidence of venous thromboembolism and its effect on survival among patients with common cancers, Arch Intern Med, 166, 458, 10.1001/archinte.166.4.458

Sørensen, 2000, Prognosis of cancers associated with venous thromboembolism, N Engl J Med, 343, 1846, 10.1056/NEJM200012213432504

Falanga, 2001, Pathogenesis of thrombosis in patients with malignancy, Int J Hematol, 73, 137, 10.1007/BF02981929

Blom, 2006, Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study, J Thromb Haemost, 4, 529, 10.1111/j.1538-7836.2006.01804.x

Fisher, 1989, A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors, N Engl J Med, 320, 479, 10.1056/NEJM198902233200802

Fisher, 1998, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371

Haddad, 2006, Chemotherapy-induced thrombosis, Thromb Res, 118, 555, 10.1016/j.thromres.2005.10.015

Khorana, 2006, Thromboembolism in hospitalized neutropenic cancer patients, J Clin Oncol, 24, 484, 10.1200/JCO.2005.03.8877

Khorana, 2005, Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study, Cancer, 104, 2822, 10.1002/cncr.21496

Lee, 2003, Venous thromboembolism and cancer: risks and outcomes, Circulation, 107, I17

Saphner, 1991, Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer, J Clin Oncol, 9, 286, 10.1200/JCO.1991.9.2.286

Fisher, 2005, Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study, J Natl Cancer Inst, 97, 1652, 10.1093/jnci/dji372

Pritchard, 1996, Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group, J Clin Oncol, 14, 2731, 10.1200/JCO.1996.14.10.2731

Bonneterre, 2001, Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma, Cancer, 92, 2247, 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y

Baum, 2002, Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial, Lancet, 359, 2131, 10.1016/S0140-6736(02)09088-8

Coombes, 2004, A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer, N Engl J Med, 350, 1081, 10.1056/NEJMoa040331

Thürlimann, 2005, A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer, N Engl J Med, 353, 2747, 10.1056/NEJMoa052258

Johnson, 2004, Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer, J Clin Oncol, 22, 2184, 10.1200/JCO.2004.11.022

Barlogie, 2006, Thalidomide and hematopoietic-cell transplantation for multiple myeloma, N Engl J Med, 354, 1021, 10.1056/NEJMoa053583

Hussein, 2006, Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations, Thromb Haemost, 95, 924, 10.1160/TH06-02-0080

El Accaoui, 2007, Thalidomide and thrombosis. A meta-analysis, Thromb Haemost, 97, 1031, 10.1160/TH06-09-0494

Palumbo, 2006, Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide, J Thromb Haemost, 4, 1842, 10.1111/j.1538-7836.2006.02059.x

Nalluri, 2008, Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis, JAMA, 300, 2277, 10.1001/jama.2008.656

Bona, 1999, Thrombotic complications of central venous catheters in cancer patients, Semin Thromb Hemost, 25, 147, 10.1055/s-2007-994916

Cunningham, 2006, Primary thromboprophylaxis for cancer patients with central venous catheters—a reappraisal of the evidence, Br J Cancer, 94, 189, 10.1038/sj.bjc.6602917

Rosovsky, 2005, Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management, Hematol Oncol Clin North Am, 19, 183, 10.1016/j.hoc.2004.09.007

Akl, 2011, Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation, Cochrane Database Syst Rev, CD006652

Sideras, 2006, Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial, Mayo Clin Proc, 81, 758, 10.4065/81.6.758

Altinbas, 2004, A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer, J Thromb Haemost, 2, 1266, 10.1111/j.1538-7836.2004.00871.x

Lebeau, 1994, Subcutaneous heparin treatment increases survival in small cell lung cancer. “Petites Cellules” Group, Cancer, 74, 38, 10.1002/1097-0142(19940701)74:1<38::AID-CNCR2820740108>3.0.CO;2-E

Akl, 2010, Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation, Cochrane Database Syst Rev, CD006466

Randolph, 1998, Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials, Chest, 113, 165, 10.1378/chest.113.1.165

Rooden, 2005, Deep vein thrombosis associated with central venous catheters—a review, J Thromb Haemost, 3, 2409, 10.1111/j.1538-7836.2005.01398.x

Cheong, 2004, High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours, Intern Med J, 34, 234, 10.1111/j.1444-0903.2004.00447.x

Tesselaar, 2004, Risk factors for catheter-related thrombosis in cancer patients, Eur J Cancer, 40, 2253, 10.1016/j.ejca.2004.06.023

Cadman, 2004, To clot or not to clot? That is the question in central venous catheters, Clin Radiol, 59, 349, 10.1016/j.crad.2003.11.015

Lee, 2006, Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer, J Clin Oncol, 24, 1404, 10.1200/JCO.2005.03.5600

Verso, 2008, Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients, Intern Emerg Med, 3, 117, 10.1007/s11739-008-0125-3

Akl, 2011, Anticoagulation for cancer patients with central venous catheters, Cochrane Database Syst Rev, CD006468

Bosson, 2006, A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices, J Intern Med, 260, 168, 10.1111/j.1365-2796.2006.01678.x

Gomes, 2003, Incidence of venous thromboembolic events among nursing home residents, J Gen Intern Med, 18, 934, 10.1046/j.1525-1497.2003.21133.x

Liperoti, 2005, Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents, Arch Intern Med, 165, 2677, 10.1001/archinte.165.22.2677

Scannapieco, 2010, Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study, Thromb Haemost, 104, 734, 10.1160/TH10-03-0169

Bosson, 2003, Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence, Arch Intern Med, 163, 2613, 10.1001/archinte.163.21.2613

Sellier, 2008, Risk factors for deep vein thrombosis in older patients: a multicenter study with systematic compression ultrasonography in postacute care facilities in France, J Am Geriatr Soc, 56, 224, 10.1111/j.1532-5415.2007.01545.x

Labarère, 2009, Low-molecular-weight heparin prophylaxis of deep vein thrombosis for older patients with restricted mobility: propensity analyses of data from two multicentre, cross-sectional studies, Drugs Aging, 26, 263, 10.2165/00002512-200926030-00007

Chandra, 2009, Meta-analysis: travel and risk for venous thromboembolism, Ann Intern Med, 151, 180, 10.7326/0003-4819-151-3-200908040-00129

Kuipers, 2007, Travel and venous thrombosis: a systematic review, J Intern Med, 262, 615, 10.1111/j.1365-2796.2007.01867.x

Kuipers, 2007, The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations, PLoS Med, 4, e290, 10.1371/journal.pmed.0040290

Lapostolle, 2001, Severe pulmonary embolism associated with air travel, N Engl J Med, 345, 779, 10.1056/NEJMoa010378

Hughes, 2003, Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study, Lancet, 362, 2039, 10.1016/S0140-6736(03)15097-0

Pérez-Rodríguez, 2003, Incidence of air travel-related pulmonary embolism at the Madrid-Barajas airport, Arch Intern Med, 163, 2766, 10.1001/archinte.163.22.2766

Kraaijenhagen, 2000, Travel and risk of venous thrombosis, Lancet, 356, 1492, 10.1016/S0140-6736(00)02878-6

Kesteven, 2002, Incidence of symptomatic thrombosis in a stable population of 650,000: travel and other risk factors, Aviat Space Environ Med, 73, 593

Cannegieter, 2006, Travel-related venous thrombosis: results from a large population-based case control study (MEGA study), PLoS Med, 3, e307, 10.1371/journal.pmed.0030307

Philbrick, 2007, Air travel and venous thromboembolism: a systematic review, J Gen Intern Med, 22, 107, 10.1007/s11606-006-0016-0

Schwarz, 2003, Venous thrombosis after long-haul flights, Arch Intern Med, 163, 2759, 10.1001/archinte.163.22.2759

ten Wolde, 2003, Travel and the risk of symptomatic venous thromboembolism, Thromb Haemost, 89, 499, 10.1055/s-0037-1613380

Schreijer, 2009, The effect of flight-related behaviour on the risk of venous thrombosis after air travel, Br J Haematol, 144, 425, 10.1111/j.1365-2141.2008.07489.x

Arfvidsson, 2000, Risk factors for venous thromboembolism following prolonged air travel. Coach class thrombosis, Hematol Oncol Clin North Am, 14, 391, 10.1016/S0889-8588(05)70140-4

Martinelli, 2003, Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives, Arch Intern Med, 163, 2771, 10.1001/archinte.163.22.2771

McQuillan, 2003, Venous thromboembolism in travellers: can we identify those at risk?, Blood Coagul Fibrinolysis, 14, 671, 10.1097/00001721-200310000-00009

Paganin, 2003, Venous thromboembolism in passengers following a 12-h flight: a case-control study, Aviat Space Environ Med, 74, 1277

Rege, 1999, Risk factors and thrombosis after airline flight, Thromb Haemost, 81, 995, 10.1055/s-0037-1614617

Scurr, 2001, Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial, Lancet, 357, 1485, 10.1016/S0140-6736(00)04645-6

Schreijer, 2006, Activation of coagulation system during air travel: a crossover study, Lancet, 367, 832, 10.1016/S0140-6736(06)68339-6

Clarke, 2006, Compression stockings for preventing deep vein thrombosis in airline passengers, Cochrane Database Syst Rev, CD004002

Belcaro, 2003, Prevention of venous thrombosis with elastic stockings during long-haul flights: the LONFLIT 5 JAP study, Clin Appl Thromb Hemost, 9, 197, 10.1177/107602960300900303

Belcaro, 2004, Prevention of venous thrombosis and thrombophlebitis in long-haul flights with pycnogenol, Clin Appl Thromb Hemost, 10, 373, 10.1177/107602960401000410

Belcaro, 2002, Prevention of edema, flight microangiopathy and venous thrombosis in long flights with elastic stockings. A randomized trial: The LONFLIT 4 Concorde Edema-SSL Study, Angiology, 53, 635, 10.1177/000331970205300603

Belcaro, 2001, Venous thromboembolism from air travel: the LONFLIT study, Angiology, 52, 369, 10.1177/000331970105200601

Cesarone, 2003, The LONFLIT4—Concorde Deep Venous Thrombosis and Edema Study: prevention with travel stockings, Angiology, 54, 143, 10.1177/000331970305400202

Cesarone, 2003, The LONFLIT4-Concorde—Sigvaris Traveno Stockings in Long Flights (EcoTraS) Study: a randomized trial, Angiology, 54, 1, 10.1177/000331970305400101

Cesarone, 2002, Venous thrombosis from air travel: the LONFLIT3 study—prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial, Angiology, 53, 1, 10.1177/000331970205300101

Cesarone, 2003, Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLIT-FLITE randomized, controlled trial, Angiology, 54, 531, 10.1177/000331970305400502

Metjian, 2009, ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?, Hematology (Am Soc Hematol Educ Program), 247, 10.1182/asheducation-2009.1.247

Segal, 2009, Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review, JAMA, 301, 2472, 10.1001/jama.2009.853

Vossen, 2005, Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT), J Thromb Haemost, 3, 459, 10.1111/j.1538-7836.2005.01197.x

Bates, 2012, VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, e691S, 10.1378/chest.11-2300

Erkan, 2002, A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome, Rheumatology (Oxford), 41, 924, 10.1093/rheumatology/41.8.924

Hereng, 2008, Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients, Lupus, 17, 11, 10.1177/0961203307084724

Tektonidou, 2009, Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies, Arthritis Rheum, 61, 29, 10.1002/art.24232

Erkan, 2007, Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals, Arthritis Rheum, 56, 2382, 10.1002/art.22663

Glynn, 2007, Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial [Summary for patients in Ann Intern Med. 2007 Oct 16;147(8):I34; PMID: 17938386], Ann Intern Med, 147, 525, 10.7326/0003-4819-147-8-200710160-00004

Undas, 2005, Statins and blood coagulation, Arterioscler Thromb Vasc Biol, 25, 287, 10.1161/01.ATV.0000151647.14923.ec

Doggen, 2004, HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women, J Thromb Haemost, 2, 700, 10.1111/j.1538-7836.2004.00696.x

Lacut, 2008, Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia?, Thromb Res, 122, 314, 10.1016/j.thromres.2007.10.014

Ramcharan, 2009, HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis, J Thromb Haemost, 7, 514, 10.1111/j.1538-7836.2008.03235.x

Sørensen, 2009, Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study, J Thromb Haemost, 7, 521, 10.1111/j.1538-7836.2009.03279.x

Yang, 2002, Statins and the risk of idiopathic venous thromboembolism, Br J Clin Pharmacol, 53, 101, 10.1046/j.0306-5251.2001.01523.x

Smeeth, 2009, Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials, Br J Clin Pharmacol, 67, 99, 10.1111/j.1365-2125.2008.03308.x

Ray, 2001, Use of statins and the subsequent development of deep vein thrombosis, Arch Intern Med, 161, 1405, 10.1001/archinte.161.11.1405

Grady, 2000, Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study, Ann Intern Med, 132, 689, 10.7326/0003-4819-132-9-200005020-00002

Glynn, 2009, A randomized trial of rosuvastatin in the prevention of venous thromboembolism, N Engl J Med, 360, 1851, 10.1056/NEJMoa0900241

Reiss, 2009, A randomized double-blind study of centoparin vs unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY Study, J Thromb Haemost, 8, 1209, 10.1111/j.1538-7836.2010.03848.x

Naccarato, 2010, Physical methods for preventing deep vein thrombosis in stroke, Cochrane Database of Systematic Reviews, 8, CD001922

Barbar, 2010, A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score, J Thromb Haemost, 8, 2450, 10.1111/j.1538-7836.2010.04044.x